# DESCRIPTION

## STATEMENT OF PRIORITY

- claim benefit of provisional applications

## FIELD OF THE INVENTION

- introduce triple negative breast cancer cell line

## BACKGROUND OF THE INVENTION

- describe breast cancer subtypes
- discuss epithelial mesenchymal transition

## SUMMARY OF THE INVENTION

- introduce novel cell line model
- describe cell line characteristics
- outline methods of using cell line
- summarize advantages of cell line

## DETAILED DESCRIPTION OF THE INVENTION

- provide detailed description of invention

## DEFINITIONS

- define "a," "an," or "the"
- define "and/or"
- define "about"
- define "nucleic acids"
- define "isolated"
- define "cell line"
- define "modulate"
- define "anticancer agent"
- define cell lines
- describe cell line production
- describe tumor production
- describe gene expression modulation
- describe metastasis modulation
- describe epithelial to mesenchymal transition modulation
- describe gene expression assays
- describe chemotherapeutic agent identification
- describe biological agent identification
- describe modulator screening

## EXAMPLES

### Example 1

- establish DKAT cell line

### Example 2

- maintain other cell lines

### Example 3

- perform cytogenetic analysis

### Example 4

- perform immunocytochemistry

### Example 5

- perform immunofluorescence

### Example 6

- perform Western blotting

### Example 7

- sequence p53 gene

### Example 8

- perform differential gene expression studies

### Example 9

- perform invasion assays
- describe cell culture conditions
- describe chemoattractant
- describe cell plating
- describe incubation conditions
- describe data analysis
- describe results

